Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Year-End Rush Of NDA Submissions Missing In 2004, But Approvals Are Up

Jan 03 2005

• By Mary Jo Laffler

Related Content

Wyeth Touts Tygacil As First Global NDA Submission

Dec 15 2004

Viagra For Pulmonary Arterial Hypertension Would Be Called Revatio

Dec 03 2004

Provigil ADHD Application Likely To Be Reviewed By New Neurological Division

Nov 04 2004

J&amp;J Submits Dapoxetine NDA For Premature Ejaculation

Dec 28 2004

Roche/GSK Preparing Boniva NDA For Once-Quarterly I.V. Formulation

Jul 08 2004

FDA Clears 31 New Molecular Entities In 2004, Up Ten From Previous Year

Jan 03 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window